Skip To Content

Study ID: Otsuka 156-13-211

Title:

Expanded access to Tempo 156-08-271 and 156-13-10

Location:
Fargo Region
Principal Investigator:
Teresa Levitski, MD
Disease:
REN (Renal)
Stage:
Phase IIIB
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.